Fact CheckerSign in

NCT06090734Active, not recruiting

Development and Evaluation of 'My Voice': A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 21 Apr 2026

Brief summary (registry, in English)

The study aims to develop and evaluate a web-based interactive platform (called 'My Voice') that helps to educate patients with heart failure and their caregivers about heart failure, identify their goals for end-of-life care, and share these with their caregivers and doctors.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
244 (estimated)
First submitted
13 Oct 2023
Start date
7 Mar 2024
Primary completion date
Mar 2027
Lead sponsor
Duke-NUS Graduate Medical School
NCT number
NCT06090734

What you commit to

  • Study type: Interventional
  • Planned participants: 244
  • From 7 Mar 2024 to the primary completion date, Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • domestic helper

Who the study is looking for

  • \- The inclusion criteria for patients are
  • Age ≥ 21 years old
  • Singaporean or Permanent Resident
  • Diagnosed with heart failure
  • Symptoms classified under NYHA class II (with an ejection fraction of less than or equal to 35%), III or IV
  • Intact cognition determined through the Abbreviated Mental Test (AMT) (for pilot testing and main RCT)
  • Ability to speak and read English, Mandarin or Malay
  • Willing to complete a web intervention
  • Easily contactable via mobile phone or landline
  • Have a permanent address in Singapore for at least the next 1 year
  • Not recruited in a previous phase of the study
    • The inclusion criteria for caregivers are
  • Age ≥ 21 years old
  • Nominated as a healthcare spokesperson by the patient or the main decision maker for the patient (for intervention arm only)
  • Ability to speak and read English, Mandarin or Malay
  • Willing to complete a web intervention
  • Easily contactable via mobile phone or landline
  • Have a permanent address in Singapore for at least the next 1 year

Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Duke-NUS
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.